Potential Advantages of Bone Marrow Sparing IMRT in Cancer Cervix: A Dosimetric EvaluationCorrespondence Address :
Dr. Sunil Choudhary,
Associate Professor, Department of Radiotherapy and Radiation Medicine Institue of Medical Science, Banaras Hindu University, Varanasi-221005, Uttar Pradesh, India.
Introduction: Concurrent Chemoradiation (CRT) is the standard of care for locally advanced cervical cancer patients. Addition of chemotherapy to pelvic radiotherapy augments Haematological Toxicity (HT). Whether reducing the radiation dose to Bone Marrow (BM) will diminish HT is yet not clear.
Aim: The purpose of the present study was to analyse the feasibility of Bone Marrow Sparing (BMS) in cervical cancer patients using Intensity Modulated Radiotherapy (IMRT).
Materials and Methods: Computed Tomography (CT) images of 10 consecutive biopsy-proven invasive cervical cancer patients were used. All patients were treated using Intensity Modulated Radiotherapy (IMRT) without bone marrow sparing (normal-IMRT). BMS-IMRT plans were generated for this study and Dose-Volume Histogram (DVH) parameters were then compared with normal-IMRT plans.
Results: The mean values of the Planning Target Volume (PTV) V95 and V97 were lower and were statistically significant (p=0.016 and 0.019 respectively) in BMS-IMRT when compared to normal-IMRT, however, PTV coverage was not compromised in any BMS-IMRT plan. There was no statistically significant difference in the mean values of rectum V30, V40, bowel V35, V40, V45, and femoral head V35. However, the mean values of rectum V50, bladder V40, V45, and V50 were statistically lower in the case of BMS-IMRT. When compared to normal-IMRT the mean values of Pelvic Bone Marrow (PBM) V10, V20, V30, V40 were lower and found to be statistically significant in BMS-IMRT.
Conclusion: The BMS-IMRT spares the PBM without compromising the target volume and at the same time spares bladder and rectum more effectively.
Cervical cancer, Haematological toxicity, Pelvic bone marrow, Volumetric modulated arc radiotherapy
Neha Gupta, Chandra Prakash, Kalpak Chakrabarty, Upendra Giri, Ankita Patel, Sunil Choudhary. POTENTIAL ADVANTAGES OF BONE MARROW SPARING IMRT IN CANCER CERVIX: A DOSIMETRIC EVALUATION. Journal of Clinical and Diagnostic Research [serial online] 2019 April [cited: 2019 Apr 22 ]; 13:XC01-XC05. Available from
Date of Submission: Oct 05, 2018
Date of Peer Review: Nov 09, 2018
Date of Acceptance: Jan 18, 2019
Date of Publishing: Apr 01, 2019
FINANCIAL OR OTHER COMPETING INTERESTS: None.
- Emerging Sources Citation Index (Web of Science, thomsonreuters)
- Index Copernicus ICV 2017: 134.54
- Academic Search Complete Database
- Directory of Open Access Journals (DOAJ)
- Google Scholar
- HINARI Access to Research in Health Programme
- Indian Science Abstracts (ISA)
- Journal seek Database
- Popline (reproductive health literature)